Universidad El Bosque, Bogotá   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Bogotá Colombia (1977)

Organization Overview

First Clinical Trial
2006
NCT00609375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

El Bosque University | Hospital Simon Bolivar, Bogota | Universidad Bosque | Universidad del bosque | Universidad El Bosque, Bogotá

Active Ingredients

Drugs in Phase 4 Trials (3)

cefepime (maxipeme) (1 trial)

heparin (liquaemin) (1 trial)

protamine sulfate (1 trial)

Drugs in Phase 3 Trials (1)

resin (1 trial)

Drugs in Phase 2 Trials (3)

amoxicillin (1 trial)

chlorhexidine (hibitane) (1 trial)

hypochlorous acid (1 trial)

Drugs in Phase 1 Trials (1)

zanamivir (relenza) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacteremia (Phase 4)

Chronic Periodontitis (Phase 2)

Dengue (Phase 1)

Dental Caries (Phase 3)

Periodontitis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8